Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

• Status: Completed
• Trial end date: 2015-05-01

Summary

To assess the long-term effects of levetiracetam on retention rate in subjects with refractory partial onset seizure that are not fully controlled with 1 to 3 concomitant antiepileptic drugs, compared to topiramate as add-on therapy during 52 weeks.

• Phase: Phase 4

Details

• Lead Sponsor: UCB Korea Co., Ltd.
• Treatments: Etiracetam; Levetiracetam; Piracetam; Topiramate